Oncology News

Surveillance of patients carrying the CDKN2A gene mutation led to earlier detection of pancreatic ductal adenocarcinoma which improved disease prognosis, according to a presenter at UEG Week.

The ACG published clinical practice guidelines on the preferred approach and management strategy for defecation disorders, proctalgia syndromes, hemorrhoids, anal fissures and fecal incontinence.

Compared with placebo, dupilumab was safe and improved eosinophilic esophagitis at 24 and 52 weeks, according to a presentation at UEG Week Virtual.

Low-cost antihypertensive drugs appeared associated with reductions in colorectal cancer-specific mortality among patients with stage I to stage III disease, according to results of a retrospective analysis published in Cancer Medicine.

The addition of nivolumab to chemotherapy showed durable benefit for treatment-naive patients with advanced gastric cancer, gastroesophageal junction cancer or esophageal adenocarcinoma, 2-year data from the CheckMate 649 study showed.

Amid lockdowns, many countries implemented a suspension of routine surveillance for colorectal cancer, resulting in fewer diagnoses in older patients with more complications, according to a presentation during UEG Week Virtual.

Healio Gastroenterology presents the following report on the top 10 peer-tested stories from September 2021.

Artificial intelligence-based computer-aided polyp detection decreased adenoma miss rate and increased first-pass adenoma per colonoscopy detection, according to research published in Clinical Gastroenterology and Hepatology.

The FDA approved cetuximab in combination with encorafenib for treatment of certain patients with colorectal cancer.

The FDA granted fast track designation to acelarin for treatment of biliary tract cancer.